Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 2, 2012, Pages 261-267

  Chung, Moon Jae ^a   Kim, Hyunki ^a   Kim, Kyung Sik ^a   Park, Sangsoo ^b   Chung, Jae Bock ^a   Park, Seung Woo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Eulji University   (South Korea)

Author keywords

Drug eluting stent; Gemcitabine; Local effect; Malignant biliary obstruction

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GEMCITABINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT DISEASE; BILIARY TRACT INFLAMMATION; CELL INFILTRATION; CONCENTRATION RESPONSE; DEVICE SAFETY; DRUG ELUTING STENT; EXPERIMENTAL PIG; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; SELF EXPANDING METALLIC BILIARY STENT; STENT;

EID: 84862910839     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06866.x     Document Type: Article

References (30)

1. Warshaw AL, Castillo CF. Pancreatic carcinoma. N. Engl. J. Med. 1992; 326: 455-65.
2. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349: 485-9.
3. Neff RA, Fankuchen EI, Cooperman AM, Helmrich ZV, Martin EC. The radiological management of malignant biliary obstruction. Clin. Radiol. 1983; 34: 143-6.
4. Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 1994; 344: 1655-60.
5. O'Brien S, Hatfield AR, Craig PI, Williams SP. A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction. Gut 1995; 36: 618-21.
6. Loew BJ, Howell DA, Sanders MK etal. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest. Endosc. 2009; 70: 445-53.
7. Born P, Neuhaus H, Rösch T etal. Initial experience with a new, partially covered Wallstent for malignant biliary obstruction. Endoscopy 1996; 28: 699-702.
8. Shim CS, Lee YH, Cho YD etal. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy 1998; 30: 345-50.
9. Kanasaki S, Furukawa A, Kane T, Murata K. Polyurethane-covered Nitinol Strecker stents as primary palliative treatment of malignant biliary obstruction. Cardiovasc. Intervent. Radiol. 2000; 23: 114-20.
10. Isayama H, Komatsu Y, Tsujino T etal. Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest. Endosc. 2002; 55: 366-70.
11. Nakai Y, Isayama H, Komatsu Y etal. Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction. Gastrointest. Endosc. 2005; 62: 742-48.
12. Isayama H, Komatsu Y, Tsujino T etal. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 2004; 53: 729-34.
13. Yoon WJ, Lee JK, Lee KH etal. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest. Endosc. 2006; 63: 996-1000.
14. Mezawa S, Homma H, Sato T etal. A study of carboplatin-coated tube for the unresectable cholangiocarcinoma. Hepatology 2000; 32: 916-23.
15. Lee DK, Kim HS, Kim KS etal. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane. Gastrointest. Endosc. 2005; 61: 296-301.
16. Lee SS, Shin JH, Han JM etal. Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model. Gastrointest. Endosc. 2009; 69: 1140-7.
17. Lee DK. Drug-eluting stent in malignant biliary obstruction. J. Hepatobiliary Pancreat. Surg. 2009; 16: 628-32.
18. Burris HA 3rd, Moore MJ, Andersen J etal. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 1997; 15: 2403-13.
19. Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br. J. Cancer. 2007; 96: 896-902.
20. Serrano A, Gerson R. Chemotherapy with gemcitabine in advanced biliary tract carcinoma. Rev. Recent Clin. Trials 2008; 3: 70-8.
21. Ueno H, Kiyosawa K, Kaniwa N. Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy? Br. J. Cancer. 2007; 97: 145-51.
22. Lee DH, Kang SG, Jeong S etal. Local delivery system of immune modulating drug for unresectable adenocarcinoma: in vitro experimental study and in vivo animal study. Cardiovasc. Intervent. Radiol. 2006; 29: 832-7.
23. Suk KT, Kim JW, Kim HS etal. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study. Gastrointest. Endosc. 2007; 66: 798-803.
24. Wassef W, Syed I. Designer stents: are we there yet? Gastrointest. Endosc. 2007; 66: 804-8.
25. Kalinowski M, Alfke H, Kleb B, Dürfeld F, Joachim Wagner H. Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction: possible topical application in malignant bile duct obstructions. Invest. Radiol. 2002; 37: 399-404.
26. Gontero P, Frea B. Actual experience and future development of gemcitabine in superficial bladder cancer. Ann. Oncol. 2006; 17 (Suppl. 5): v123-8.
27. Bethge N, Sommer A, Gross U, von Kleist D, Vakil N. Human tissue responses to metal stents implanted in vivo for the palliation of malignant stenoses. Gastrointest. Endosc. 1996; 43: 596-602.
28. Hausegger KA, Kleinert R, Lammer J, Klein GE, Flückiger F. Malignant biliary obstruction: histologic findings after treatment with self-expandable stents. Radiology 1992; 185: 461-4.
29. Thijssen AM, Millward SF, Mai KT. Ureteral response to the placement of metallic stents: an animal model. J. Urol. 1994; 151: 268-70.
30. Reddy MP, Venugopal A, Subrahmanyam M. Hydroxyapatite-supported Ag-TiO2 as Escherichia coli disinfection photocatalyst. Water Res. 2007; 41: 379-86.